Piramal Pharma Ltd. (PPLPHARMA) Share Price Hits Fresh 52-Week High

Piramal Pharma Ltd. Share Price hits a fresh 52-week high at Rs 212.45, up 1.79% today. Market cap stands at Rs 26,946.49 Cr.

Piramal Pharma Ltd. Share Price has reached a fresh 52-week high of Rs 212.45, marking a 1.79% increase from the previous close of Rs 206.5. The current market capitalisation of the company is Rs 26,946.49 crore. This milestone highlights the stock's recent upward momentum in the market. Despite the absence of a specific catalyst, the stock's performance is noteworthy in the context of its sector and peer benchmarks. Investors are closely monitoring the stock's trajectory as it continues to capture attention in the healthcare sector.

Piramal Pharma Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 210.2
Previous Close	Rs 206.5
Today's Change	+Rs 3.7 (+1.79%)
Day Open	Rs 206.25
Fresh 52-Week High	Rs 212.45
Day Low	Rs 204.85
Current Volume	1,21,732
Turnover	Rs 2.56 crore
Market Capitalisation	Rs 26,946.49 crore

Piramal Pharma Ltd. (PPLPHARMA) traded at Rs 210.2. versus the previous close of Rs 206.5, a rise of 1.79%. The stock opened at Rs 206.25, reached Rs 212.45, touched Rs 204.85. Reported volume was 1,21,732.

Today, Piramal Pharma Ltd. opened at Rs 206.25 and reached a high of Rs 212.45, setting a new 52-week peak. The stock's low for the day was Rs 204.85, with a turnover of Rs 2.56 crore. The current volume of 121,732 shares indicates active market participation. This price action underscores the stock's resilience and investor interest, even as the broader market dynamics remain fluid. The stock's recent performance sets the stage for further analysis of its fundamentals and sector positioning.

Piramal Pharma Ltd. (PPLPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 26,946.49 crore
P/E Ratio	31.4x
P/B Ratio	0.46x
ROE	-2.89%
ROCE	-0.26%

Piramal Pharma Ltd. was valued at a P/E ratio of 31.4x, a P/B ratio of 0.46x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	31.4x
Benchmark Median P/E	21.61x
Benchmark Average P/E	72.01x
Benchmark P/E Range	0x to 3,428.55x
Company P/B Ratio	0.46x
Benchmark Median P/B	1.92x
Company ROE	-2.89%
Benchmark Median ROE	10.75%
Company ROCE	-0.26%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 26,946.49 crore
Benchmark Median Market Cap	Rs 139.72 crore

Piramal Pharma Ltd. (PPLPHARMA) is classified under sector: Healthcare.

Piramal Pharma Ltd. (PPLPHARMA) has a P/E ratio of 31.4x, which is above the benchmark median of 21.61x, a difference of +45.3%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Piramal Pharma Ltd. (PPLPHARMA) has a ROE of -2.89%, which is below the benchmark median of 10.75%, a difference of -126.88%. Piramal Pharma Ltd. (PPLPHARMA) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,943.6	31.4	0.46	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,684.11	39.39	8.02	28.21	26.35
Beta Drugs Ltd.	BETA	2,621.81	63.25	10.01	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,511.89	32.96	6.79	-2.6	16.92
Sai Parenteral's Ltd.	SAIPARENT	2,347.02	160.63	2.97	13.9	12.97

Piramal Pharma Ltd. (PPLPHARMA) has a P/E ratio of 31.4x compared with the displayed peer median of 39.39x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Piramal Pharma Ltd. (PPLPHARMA) has a market capitalisation of Rs 26,946.49 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Piramal Pharma Ltd.

• Achieved a fresh 52-week high at Rs 212.45, indicating strong price momentum.
• Market capitalisation of Rs 26,946.49 crore positions it as a significant player in the healthcare sector.
• Mixed fundamental indicators with a P/E of 31.4 and P/B of 0.46.
• Sector and peer analysis reveal competitive positioning despite challenges in ROE and ROCE.

About Piramal Pharma Ltd.

Piramal Pharma Ltd. operates in the healthcare sector, focusing on pharmaceuticals and drugs. The company is involved in the development, manufacturing, and distribution of a wide range of pharmaceutical products. With a significant market presence, Piramal Pharma is a key player in the industry, offering a diverse portfolio of products that cater to various therapeutic areas. The company's strategic initiatives and operational capabilities position it as a prominent entity within the healthcare landscape.

Track Piramal Pharma Ltd. Share Price on Univest

Use Piramal Pharma Ltd. (PPLPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors can track the live share price of Piramal Pharma Ltd., along with technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights on Univest. This platform provides comprehensive data and analysis to support informed investment decisions.

Frequently Asked Questions

What is the current share price of Piramal Pharma Ltd.?

Ans. The current share price of Piramal Pharma Ltd. is Rs 210.2, reflecting a 1.79% increase from the previous close of Rs 206.5. The stock moved 1.79% during the session. The intraday range extended from Rs 204.85 to Rs 212.45.

What is the market capitalisation of Piramal Pharma Ltd.?

Ans. Piramal Pharma Ltd. has a market capitalisation of Rs 26,946.49 crore, positioning it as a significant player in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 31.4x.

How does Piramal Pharma Ltd.'s P/E ratio compare to the sector median?

Ans. Piramal Pharma Ltd.'s P/E ratio of 31.4 is above the sector median of 21.61, indicating a relatively higher valuation compared to its peers. The company trades at a P/E ratio of 31.4x.

What is the 52-week high of Piramal Pharma Ltd.?

Ans. The 52-week high of Piramal Pharma Ltd. is Rs 212.45, achieved recently, marking a significant milestone for the stock. The stock moved 1.79% during the session. The intraday range extended from Rs 204.85 to Rs 212.45.

How does Piramal Pharma Ltd.'s P/B ratio compare to the sector median?

Ans. Piramal Pharma Ltd.'s P/B ratio of 0.46 is significantly below the sector median of 1.92, suggesting potential undervaluation. The company trades at a P/E ratio of 31.4x. Its P/B ratio is 0.46x.

What are the ROE and ROCE of Piramal Pharma Ltd.?

Ans. Piramal Pharma Ltd. has a negative ROE of -2.89% and ROCE of -0.26%, indicating challenges in generating returns on equity and capital employed. ROE stands at -2.89%. ROCE stands at -0.26%.

How does Piramal Pharma Ltd. compare to its peers?

Ans. Piramal Pharma Ltd. has a substantial market cap of Rs 26,946.49 crore, with a P/E of 31.4, positioning it competitively among peers like Dishman Carbogen and Kwality Pharmaceuticals. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta.

Where can I track Piramal Pharma Ltd. share price?

Ans. Investors can track Piramal Pharma Ltd. share price and other market insights on Univest, a platform offering comprehensive data and analysis. The stock moved 1.79% during the session. The intraday range extended from Rs 204.85 to Rs 212.45.